Analyst Shrikant Chouhan from Kotak Securities has recommended buying stocks of SBI Life Insurance and Galaxy Surfactants. SBI Life, a major player in India's private insurance sector, achieved a remarkable ₹1 trillion in Gross Written Premium (GWP) for FY26, reflecting a 19% year-on-year growth. The company holds a 22.9% market share among private insurers and is shifting its focus towards higher-margin protection and traditional plans. Despite a slight dip in net profit, SBI Life's new business premium surged by 20% to ₹42,550 crore. Meanwhile, Galaxy Surfactants, a leading specialty chemicals firm, is navigating temporary challenges but is expected to rebound. The company is not merely a commodity player but focuses on differentiated, consumer-facing products, serving over 1,500 clients across 80+ countries. Their Vision 2030 aims to enhance their global footprint, particularly in North America and Europe. Both companies are well-positioned for future growth, with SBI Life's strong market presence and Galaxy's innovative product offerings.